Quantcast

Latest Renal cell carcinoma Stories

2011-06-21 13:50:00

ATLANTA, June 21, 2011 /PRNewswire/ -- MDOUTLOOK®, the global oncology intelligence initiative powered by The Arcas Group, announced results from 4th Annual Quick Poll research launched immediately following this month's annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. These Quick Polls expand on previous Quick Polls carried out after the past 3 ASCO annual meetings, as well as similar efforts after the American Society of Hematology (ASH)...

2011-06-15 02:00:00

TUEBINGEN, Germany, June 15, 2011 /PRNewswire/ -- igoommatics biotechnologies GmbH, a biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announced today that the first patients have been vaccinated in the IMPRINT study, a pivotal Phase III trial with IMA901, the company's lead cancer vaccine for the treatment of renal cell carcinoma (RCC). The trial is designed to demonstrate the overall survival benefit of IMA901 in...

2011-06-08 06:51:45

(Ivanhoe Newswire) -- About 50,000 Americans are diagnosed with kidney cancer every year, but a new form of radioimmuntherapy may decrease this number significantly. Radioimmunotherapy zeroes in on antigens associated with kidney cancer cells. Patients with progressive kidney cancer receiving as much as three times the dosage show dramatic slowing of cancer growth and stabilization of their disease. "This study is another step forward in developing a cancer therapy that has the potential to...

2011-06-05 10:00:00

DURHAM, N.C., June 5, 2011 /PRNewswire/ -- Argos Therapeutics today announced that new data from its Phase 2 combination study of its Arcelis(TM) immunotherapy for the treatment of renal cell carcinoma (RCC), AGS-003, in combination with sunitinib showed improvement over expectations for sunitinib alone in progression-free survival (PFS) in newly diagnosed metastatic RCC patients with unfavorable prognosis. Induction of anti-tumor (CD28+) memory T cell responses correlated with PFS and...

2011-06-02 01:11:00

Results suggest that lymphocyte count could factor into doctors' treatment decisions Each year, kidney cancer is diagnosed in nearly 60,000 people in the U.S. Many of these patients undergo surgery to remove the affected kidney, but this procedure can be risky for the elderly and those who have other health problems. Unfortunately, the prognosis of kidney cancer patients often cannot be determined until tumor samples are surgically removed and evaluated. Now, researchers at Fox Chase Cancer...

2011-06-01 07:00:00

DURHAM, N.C., June 1, 2011 /PRNewswire/ -- Argos Therapeutics announced today that its Arcelis(TM) immunotherapy for the treatment of renal cell carcinoma (RCC), AGS-003, in combination with sunitinib demonstrated a strong immunologic response that correlated to improved clinical outcomes. The Phase 2 combination study in newly diagnosed, metastatic RCC patients with unfavorable prognosis demonstrated decreases in T regulatory cells, along with a concurrent expansion of CD28+memory...

2011-05-26 00:00:28

Fellow to work with renowned researcher Dr. Richard Childs at NHLBI Bethesda, MD (PRWEB) May 25, 2011 The Foundation for the National Institutes of Health (FNIH) is pleased to announce today that Quinn Weisman has been awarded the first Rancic-O'Neill Fellowship, made possible by a partnership between the Dr. Edward T. Rancic Memorial Fund and the Dean R. O'Neill Renal Cell Cancer Fund, in support of research for renal cell carcinoma - or kidney cancer - at the National Institutes of Health...

2011-05-20 15:34:00

SILVER SPRING, Md., May 20, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Sutent (sunitinib) to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body (metastatic). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) Neuroendocrine tumors found in the pancreas are slow-growing and rare. It is estimated that there are fewer than...

2011-05-19 22:55:59

Researchers at the University of Oxford have developed a cheap and reliable diagnostic test for a rare form of cancer. The test involves screening tumour samples for a particular molecular fingerprint unique to this type of cancer. Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a disorder which causes the development of benign but often painful tumours in the skin and, in females, in the uterus. Between one in six and one in ten people affected by the disorder will go on to...

2011-05-19 11:44:23

Results suggest that lymphocyte count could factor into doctors' treatment decisions Each year, kidney cancer is diagnosed in nearly 60,000 people in the U.S. Many of these patients undergo surgery to remove the affected kidney, but this procedure can be risky for the elderly and those who have other health problems.  Unfortunately, the prognosis of kidney cancer patients often cannot be determined until tumor samples are surgically removed and evaluated. Now, researchers at Fox Chase...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'karpos', fruit.
Related